Delivery Order SPE2DE24D0013-SPE2D626F3776

Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $1,417.52 on October 22, 2025, by the Defense Logistics Agency Medical Supply Chain under a firm fixed-price contract structure. The delivery order, designated XPRSMVP-10, is scheduled for completion by October 29, 2025, with performance occurring at Cepheid's Sunnyvale facility. This award was made without a set-aside designation, reflecting Cepheid's competitive positioning in the federal molecular diagnostics procurement market. The contract falls under the Defense Logistics Agency's medical supply chain procurement operations, which support diagnostic testing capabilities across the Department of Defense and other federal healthcare entities.

Cepheid has established itself as a primary federal supplier of molecular diagnostic solutions, particularly through its GeneXpert diagnostic platform and associated testing capabilities. The company maintains extensive existing contracts with multiple federal agencies, including the Department of Veterans Affairs through two significant Indefinite Delivery Contracts valued at approximately $6.7 million and $32.8 million respectively, the Indian Health Service, the Defense Health Agency, and the U.S. Coast Guard. These contracts typically involve the supply of diagnostic reagents, test kits for infectious disease detection including COVID-19, influenza, and respiratory pathogens, and maintenance services for diagnostic equipment. Cepheid's federal portfolio demonstrates consistent reliance on firm fixed-price structures and reflects the company's core competency in providing rapid molecular diagnostic testing solutions to support clinical laboratory operations across the federal healthcare system.